Invesco India Pharma And Healthcare Fund
Monthly portfolio · 1 months through Sep-2026
compared to — · as on September 30, 2026
Holdings
13
Scheme AUM
₹436 cr
New
13
Exited
0
Increased
0
Reduced
0
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| New | Max Healthcare Institute Limited INE027H01010 | Healthcare Services | 4,48,697 | — | 9.58% | — | ₹41.72 cr |
| New | Sun Pharmaceutical Industries Limited INE044A01036 | Pharmaceuticals & Biotechnology | 2,15,600 | — | 8.99% | — | ₹39.17 cr |
| New | Sai Life Sciences Limited INE570L01029 | Pharmaceuticals & Biotechnology | 2,46,478 | — | 8.63% | — | ₹37.58 cr |
| New | Apollo Hospitals Enterprise Limited INE437A01024 | Healthcare Services | 42,818 | — | 8.03% | — | ₹34.96 cr |
| New | Manipal Health Enterprises Ltd INE459N01021 | Healthcare Services | 4,90,483 | — | 7.98% | — | ₹34.74 cr |
| New | Divi's Laboratories Limited INE361B01024 | Pharmaceuticals & Biotechnology | 36,777 | — | 7.85% | — | ₹34.17 cr |
| New | Global Health Limited INE474Q01031 | Healthcare Services | 2,23,244 | — | 7.00% | — | ₹30.47 cr |
| New | Dr Agarwals Health Care Limited INE943P01029 | Healthcare Services | 5,74,524 | — | 6.32% | — | ₹27.54 cr |
| New | Corona Remedies Limited INE02ZQ01018 | Pharmaceuticals & Biotechnology | 1,27,543 | — | 6.13% | — | ₹26.7 cr |
| New | Torrent Pharmaceuticals Limited INE685A01028 | Pharmaceuticals & Biotechnology | 44,689 | — | 4.93% | — | ₹21.45 cr |
| New | Glenmark Pharmaceuticals Limited INE935A01035 | Pharmaceuticals & Biotechnology | 90,716 | — | 4.86% | — | ₹21.18 cr |
| New | Krishna Institute Of Medical Sciences Limited INE967H01025 | Healthcare Services | 2,75,638 | — | 4.72% | — | ₹20.57 cr |
| New | Aster DM Quality Care Limited INE914M01019 | Healthcare Services | 1,24,423 | — | 1.99% | — | ₹8.67 cr |
Cash & other
| Triparty Repo | 20.56% | ₹89.55 cr |
| Net Receivables / (Payables) | -7.57% | ₹-32.96 cr |
